Clinilabs and Ambulatory Monitoring. Inc., Form Strategic Alliance


Company News Release

Clinilabs has entered into a strategic alliance withAmbulatory Monitoring, Inc. (AMI), a medical device and service company.

AMI, located in Ardsley, NY, provides equipment for monitoring physiological functioning in ambulatory subjects. The company’s series of Motionlogger® Actigraphs are commercial devices for 24-hour monitoring of activity and sleep and have been validated through use in hundreds of studies in numerous clinical populations. AMI’s activity monitors can be applied in clinical trials of therapeutics for sleep, psychiatric, pain, hyperactivity, dermatologic (e.g., itch), and cardiovascular disorders, among others. AMI also providesthe original PVT-192 Psychomotor Vigilance Task Monitor.

The alliance brings together AMI’s instrumentation with Clinilabs’ core laboratory. Clinilabs’ core laboratory aggregates and processes electrocardiographic (ECG), polysomnographic (PSG), electroencephalographic (EEG), and electromyographic (EMG) data for clinical studies, offering pharmaceutical companies centralized services that standardize data obtained in multicenter trials. Centralized actigraphy has been offered jointly by Clinilabs and AMI since 2005.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.